Cell and Gene Outsourcing

  1. Pioneering Plasmid-IQ Design 5/13/2025

    Gain insights into the significance of plasmid design in viral vector production and the use of analytical assays and Next-Generation Sequencing for plasmid verification.

  2. 3 Strategies For A Successful Journey Toward Cell And Gene Therapy Commercialization 5/13/2025

    CTMC's Amy Hay provides 3 recommendations for teams developing cell and gene therapies, from clinical research through commercialization.

  3. Global Access To Cell And Gene Therapy: ARM Studios Interview With Boro Dropulić 5/9/2025

    Don’t miss this compelling interview with Boro Dropulić, CEO of Caring Cross, on how the cell and gene therapy sector can turn scientific breakthroughs into global health solutions.

  4. Enabling The Future Of Gene Therapy Through Decentralized Vector Manufacturing 5/9/2025

    Discover how scalable innovation is transforming viral vector production and driving broader, more equitable access to advanced gene therapies.

  5. Caring Cross: Boro Dropulić's Big Idea That Might Change The World 5/9/2025

    With real-world examples and a vision that challenges the prevailing norms of biotech commercialization, this conversation offers a powerful look at what it takes to reshape the future of healthcare.

  6. April 2025 — CDMO Opportunities And Threats Report 5/8/2025

    Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

  7. Powering Gene Therapy Progress With High-Performance Lentiviral Vectors 5/7/2025

    Accelerate your gene therapy pipeline with our cost-effective, high-quality lentiviral vectors, optimized for clinical and commercial success.

  8. Oligonucleotide Lipid Nanoparticle Production And Characterization 5/7/2025

    Advancing safe and effective oligonucleotide delivery requires microfluidic mixing to produce lipid nanoparticles with precise size control, stability, and scalability.

  9. Advancing Drug Development With Optimized LC-MS/MS Bioanalysis 5/7/2025

    Explore the critical role of sample preparation optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical method development.

  10. Your CDMO Partner From CMC Development To Commercial Supply 5/1/2025

    Discover a platform that offers clients a personalized, responsive, and expert-driven approach to process development and manufacturing from early clinical to pivotal supply and commercial launch.